Press Releases
 
Press Releases
  Date Title and Summary View
Jul 21, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corporation (NASDAQ: EXAS) today announced that Jefferies LLC and Robert W. Baird & Co. Incorporated, the underwriters of the Company's previously announced public offering of 7,000,000 shares of common stock, are reoffering the shares to the public at an initial ...
Jul 20, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corporation (NASDAQ: EXAS) today announced an agreement to sell 7,000,000 shares of its common stock to Jefferies LLC and Robert W. Baird & Co. Incorporated as underwriters in an underwritten public offering pursuant to an effective shelf registration statement file...
Jul 20, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced its business and financial results for the second quarter of 2015, and showed continued strong performance with more than 21,000 completed Cologuard tests for the quarter, up more than 90 percent from the first quarter, which ...
Jul 16, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host webcasts and conference calls to discuss its second-quarter 2015 financial results and of its annual stockholders meeting. Second-Quarter 2015 Webcast & Conference Call Details ...
Jul 14, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host webcasts and conference calls to discuss its second-quarter 2015 financial results and of its annual stockholders meeting. Second-Quarter 2015 Webcast & Conference Call Details ...
Jun 25, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced that it expects to end the second quarter of 2015 with approximately 21,000 completed Cologuard tests. More than 13,800 physicians ordered at least one Cologuard test since the October 2014 launch and the...
Jun 16, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced that it will provide a live video webcast and conference call for its Investor & Analyst Day on June 25. The event will focus on the Exact Sciences' strong foundation for growth, including Cologuard and E...
Jun 4, 2015
Molecular Diagnostics Leader and Preeminent Cancer Research Institution's Moon Shots Program Launch Initiative to Identify Lung Cancer in Early Stages MADISON, Wis., & HOUSTON--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) and The University of Texas MD Anderson Can...
May 26, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced that it will participate in three investor conferences during June to highlight the company's commercial strategy that's driving the strong early growth of Cologuard. Kevin Conroy, the company's chairman ...
May 15, 2015
WASHINGTON--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced that data supporting its stool DNA (sDNA) screening platform for colorectal cancer and other screening techniques for the detection of additional gastrointestinal cancers and diseases will be presented in five posters at Di...
Page:
1
... NextLast
= add release to Briefcase